• Human LILRA2/CD85h/ILT1 protein (Recombinant) (C-His-Avi) {Biotin} (STJP001667)
  • Human LILRA2/CD85h/ILT1 protein (Recombinant) (C-His-Avi) {Biotin} (STJP001667)
  • Human LILRA2/CD85h/ILT1 protein (Recombinant) (C-His-Avi) {Biotin} (STJP001667)

Human LILRA2/CD85h/ILT1 protein (Recombinant) (C-His-Avi) {Biotin} (STJP001667)

SKU:
STJP001667

Shipping:
Free Shipping
Current Stock:
Host: HEK293
Note: STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human LILRA2/CD85h/ILT1-C-His-Avi protein was developed from hek293 and has a target region of C-His-Avi. For use in research applications.
Conjugation: Biotin
Formulation: Lyophilised from 0.2 µm filtered PBS solution pH7.4.
Dilution Range: Upon receipt centrifuge vial to ensure maximal product extraction, recommended: 20sec, 5K RPM
Storage Instruction: The lyophilized protein is stable for at least 1 year from date of receipt at-20°C.
Endotoxin: Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg).
Gene Symbol: LILRA2
Gene ID: 11027
Uniprot ID: LIRA2_HUMAN
Immunogen Region: Gly24-Asn449
Immunogen: DNA sequence encoding Human LILRA2/CD85h/ILT1 including a C-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology.
Function Part of the innate immune responses against microbial infection. Specifically recognizes a set of N-terminally truncated immunoglobulins that are produced via cleavage by proteases from a range of pathogenic bacteria and fungi, including L.pneumophila, M.hyorhinis, S.pneumoniae, S.aureus and C.albicans. Recognizes epitopes that are in part in the variable region of the immunoglobulin light chains, but requires also the constant region for signaling. Binds to a subset of cleaved IgM, IgG3 and IgG4 molecules, but does not bind cleaved IgA1. Binding of N-terminally truncated immunoglobulins mediates activation of neutrophils. In monocytes, activation leads to the release of CSF2, CF3, IL6, CXCL8 and CCL3 and down-regulates responses to bacterial lipopolysaccharide (LPS), possibly via down-regulation of TLR4 expression and reduced signaling via TLR4. In eosinophils, activation by ligand binding leads to the release of RNASE2, IL4 and leukotriene C4. Does not bind class I MHC antigens.
Protein Name Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2
Cd85 Antigen-Like Family Member H
Immunoglobulin-Like Transcript 1
Ilt-1
Leukocyte Immunoglobulin-Like Receptor 7
Lir-7
Cd Antigen Cd85h
Database Links Reactome: R-HSA-198933
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Isoform 4: Secreted
Alternative Protein Names Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2 protein
Cd85 Antigen-Like Family Member H protein
Immunoglobulin-Like Transcript 1 protein
Ilt-1 protein
Leukocyte Immunoglobulin-Like Receptor 7 protein
Lir-7 protein
Cd Antigen Cd85h protein
LILRA2 protein
ILT1 protein
LIR7 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance